Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

類似資料

• A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients
  著者:: Yang, L, 等
  出版事項: (2017)
• A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
  著者:: Eustace, A, 等
  出版事項: (2013)
• Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
  著者:: Eustace, A, 等
  出版事項: (2013)
• Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
  著者:: Eustace, A, 等
  出版事項: (2013)
• Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
  著者:: Mutian Lian, 等
  出版事項: (2023-12-01)